(Q53785263)

English

Amantadine versus L-2 dopa and amatadine plus L-dopa.

scientific article

AMANTADINE VERSUS L-DOPA AND AMANTADINE PLUS L-DOPA

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

Amantadine versus L-2 dopa and amatadine plus L-dopa. (English)

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

1

object named as

C Fieschi

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

2

object named as

M Nardini

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

3

object named as

M Casacchia

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

4

object named as

M E Tedone

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

5

object named as

M Reitano

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

6

object named as

E Robotti

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

language of work or name

0 references

publication date

1 July 1970

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

2

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

7664

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

154-155

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

Controlled trial of amantadine hydrochloride in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992742-X

7 January 2021

based on heuristic

inferred from DOI database lookup

[The treatment of parkinsonism with amantadine]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992742-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amantadine for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992742-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Amantadine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992742-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Herpes encephalitis treated with intravenous idoxuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2992742-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(70)92742-X

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/4194541

Semantic Scholar paper ID

b1327a2fa1d44680195771c1c5b35fee736c7b39

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53785263&oldid=1398819100"